Varian Medical Systems (VAR) : Traders are bullish on Varian Medical Systems (VAR) as it has outperformed the S&P 500 by a wide margin of 3.79% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 1.22%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 1.39% in the last 1 week, and is up 3.24% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 2.9% and the 50-Day Moving Average is 4.92%.The 200 Day SMA reached 18.27%
Varian Medical Systems (NYSE:VAR): After opening at $99.12, the stock dipped to an intraday low of $99.07 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $100.07 and the buying power remained strong till the end. The stock closed at $99.53 for the day, a gain of 1.00% for the day session. The total traded volume was 1,152,026. The stocks close on the previous trading day was $99.53.
Varian Medical Systems (VAR) : 4 investment research analysts covering Varian Medical Systems (VAR) have an average price target of $97.25 for the near short term. The highest target price given by the Brokerage Firm to the stock is $102 and the lowest target is $90 for the short term. Analysts expect the variance to be within $5.12 of the average price.
Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Companys products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Companys customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors offices and cancer care clinics.